参考文献/References:
[1] BOOR P,OSTENDORF T,FLOEGE J.Renal fibrosis:novel insights into mechanisms and therapeutic targets[J].Nat Rev Nephrol,2010,6(11):643-656.
[2] GUITERAS R,FLAQUER M,CRUZADO J M.Macrophage in chronic kidney disease[J].Clin Kidney J,2016,9(6):765-771.
[3] SICA A,MANTOYANI A.Macrophage plasticity and polarization:in vivo veritas[J].J Clin Invest,2012,122(3):787-795.
[4] FAN F,ROMAN R J.Effect of cytochrome P450 metabolites of arachidonic acid in nephrology[J].J Am Soc Nephrol,2017,28(10):2845-2855.
[5] HASHIMOTO T,FANG Y I,OHATA H,et al.Change in soluble epoxide hydrolase (sEH) during cisplatin-induced acute renal failure in mice[J].J Toxicol Sci,2015,40(4):451-457.
[6] BETTAICH A,KOIKE S,CHAHED S,et al.Podocyte-specific soluble epoxide hydrolase deficiency in mice attenuates acute kidney injury[J].FEBS J,2017,284(13):1970-1986.
[7] KIM J,IMIG J D,YANG J,et al.Inhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammation[J].Am J Physiol Renal Physiol,2014,307(8):F971-F980.
[8] WANG Q,PANG W,CUI Z,et al.Upregulation of soluble epoxide hydrolase in proximal tubular cells mediated proteinuria-induced renal damage[J].Am J Physiol Renal Physiol,2013,304(2):F168-F176.
[9] ROCHE C,GUERROT D,HAROUKI N,et al.Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice[J].Prostaglandins Other Lipid Mediat,2015,120:148-154.
[10] ZHANG L,WANG F,WANG L,et al.Prevalence of chronic kidney disease in China:a cross-sectional survey[J].Lancet,2012,379(9818):815-822.
[11] ROCKEY D C,BELL P D,HILL J A.Fibrosis-A common pathway to organ injury and failure[J].N Engl J Med,2015,373(1):96.
[12] LEE S,HUEN S,NISHINO H,et al.Distinct macrophage phenotypes contribute to kidney injury and repair[J].J Am Soc Nephrol,2011,22(2):317-326.
[13] LECH M,GROBMAYR R,RYU M,et al.Macrophage phenotype controls long-term AKI outcomes:kidney regeneration versus atrophy[J].J Am Soc Nephrol,2014,25(2):292-230.
[14] ANDERS H J,RYU M.Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis[J].Kidney Int,2011,80(9):915-925.
[15] WANG Y,WANG Y P,ZHENG G,et al.Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease[J].Kidney Int,2007,72(3):290-299.
[16] TIAN S,ZHANG L,TANG J,et al.HMGB1 exacerbates renal tubulointerstitial fibrosis through facilitating M1 macrophage phenotype at the early stage of obstructive injury[J].Am J Physiol Renal Physiol,2015,308(1):F69-F75.
[17] DAI M,WU L,HE Z,et al.Epoxyeicosatrienoic acids regulate macrophage polarization and prevent LPS-induced cardiac dysfunction[J].J Cell Physiol,2015,230(9):2108-2119.
[18] LOPEZ C,ALCARAZ J,GARCIA V,et al.Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver:role for omega-3 epoxides[J].Proc Natl Acad Sci USA,2015,112(2):536-541.
[19] DAI M,WU L,WANG P,et al.CYP2J2 and its metabolites EETs attenuate insulin resistance via regulating macrophage polarization in adipose tissue[J].Sci Rep,2017,7:46743.
相似文献/References:
[1]赵颖丹,张天嵩,马 骏,等.细颗粒物2.5在肾小管上皮细胞氧化损伤中的作用及其调控机制[J].新乡医学院学报,2020,37(12):1118.[doi:10.7683/xxyxyxb.2020.12.004]
ZHAO Yingdan,ZHANG Tiansong,MA Jun,et al.Role of particulate matter 2.5 in oxidative damage of renal tubular epithelial cells and its regulatory mechanism[J].Journal of Xinxiang Medical University,2020,37(5):1118.[doi:10.7683/xxyxyxb.2020.12.004]